Who are Israel's best doctors in each field? jpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jpost.com Daily Mail and Mail on Sunday newspapers.
On Track to Dose the First Patient in the Phase 1 Study Evaluating Belzupacap Sarotalocan (AU‑011) for the Treatment of Non-Muscle Invasive Bladder Cancer in Q3 2022On Track to Initiate Pivotal Trial in Early-Stage Choroidal Melanoma in Q4 2022BOSTON (BUSINESS WIRE) Aura Biosciences Inc. (NASDAQ: AURA), a clinical.
11.08.2022 - Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today reported financial results for the second quarter ended June .
KNOXVILLE, TN, June 30, 2022 (GLOBE NEWSWIRE) Provectus (OTCQB: PVCT) today announced that updated data from the Company’s initial expansion cohort of.
Castle Biosciences Inc. (CSTL) Patients with Uveal Melanoma Tested with DecisionDx-UM Report Gaining Value from Test Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.